DOCSLIB.ORG

For Self-Specific CD8 T Cells Functions As an Effective Cytolytic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
For Self-Specific CD8 T Cells Functions As an Effective Cytolytic The Low Affinity Fc Receptor for IgG Functions as an Effective Cytolytic Receptor for Self-Specific CD8 T Cells This information is current as Salim Dhanji, Kathy Tse and Hung-Sia Teh of September 28, 2021. J Immunol 2005; 174:1253-1258; ; doi: 10.4049/jimmunol.174.3.1253 http://www.jimmunol.org/content/174/3/1253 Downloaded from References This article cites 24 articles, 11 of which you can access for free at: http://www.jimmunol.org/content/174/3/1253.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Low Affinity Fc Receptor for IgG Functions as an Effective Cytolytic Receptor for Self-Specific CD8 T Cells1 Salim Dhanji, Kathy Tse, and Hung-Sia Teh2 We have recently described a population of self-Ag-specific murine CD8؉ T cells with a memory phenotype that use receptors of both the adaptive and innate immune systems in the detection of transformed and infected cells. In this study we show that upon activation with IL-2 with or without Ag, between 10 and 20% of the activated self-specific CD8؉ T cells express the low affinity FcR for IgG. By contrast, all IL-2-activated NK cells express high levels of this FcR. The FcR comprises the Fc␥RIII␣ and FcR␥ subunits. However, the FcR␥ subunit also associates with the CD3 complex, and this association probably contributes to the low expression of FcR in activated cells. Although the FcR is expressed at a low level on activated self-specific CD8؉ T cells, it functions very efficiently as a cytolytic receptor in ADCC. FcR-dependent killing occurred in the absence of TCR stimulation, but could be ؉ augmented by concurrent stimulation of the TCR. In addition to mediating ADCC, engagement of the FcR on self-specific CD8 Downloaded from T cells results in the production of both IFN-␥ and TNF-␣. This is the first report of an activating FcR on self-specific murine CD8؉␣␤ TCR؉ T cells and establishes the importance of innate immune system receptors in the function of these self-specific .CD8؉ T cells. The Journal of Immunology, 2005, 174: 1253–1258 atural killer cells represent a highly specialized lym- Fc␥RIII␣ associates mainly with ITAM-containing homo- or het- ␨ ⑀ ␥ ␥ phoid population characterized by potent cytolytic ac- erodimers of CD3 and Fc RI (FcR ) in humans (8) or solely http://www.jimmunol.org/ N tivity against tumor or virally infected cells. Their func- with FcR␥ homodimers in mice (9). The binding of IgG to CD16 tion is finely regulated by a series of inhibitory or activating results in the phosphorylation of ITAMs in the signaling chains, receptors (1). The inhibitory receptors, specific for MHC class I leading to the recruitment of kinases such as ZAP-70 and Syk (10). molecules, allow NK cells to discriminate between normal cells These kinases initiate a signaling cascade resulting in the lysis of and cells that have lost the expression of MHC class I (e.g., tumor Ab-coated target cells. T cells also use ITAM-containing receptors cells). Inhibitory receptors, such as those belonging to the Ly49 and Syk and ZAP-70 for their signal transduction (reviewed in Ref. family in mice and the killer Ig-like receptors in humans, contain 11). Thus, the signals transduced by the engagement of CD16 on ITIM motifs in their cytoplasmic domains (2). Engagement of NK cells are very similar to those transduced by the engagement of these receptors results in the recruitment of inhibitory phospha- TCR on T cells. by guest on September 28, 2021 tases that prevent NK cell activation. The activating receptors re- CD16 expression is not limited to NK cells; other cell types sponsible for NK cell triggering include NKp46, NKp30, NKp44, have been described that also express this receptor. ␥␦ T cells have and NKG2D in humans and NKp46 and NKG2D in mice (3, 4). been shown to express CD16, as have a population of large gran- The activating receptors, some of which belong to the same fam- ϩ Ϫ Ϫ ular lymphocytes (mostly ␣␤TCR CD4 CD8 T cells) in hu- ilies, do not contain activation motifs, but, rather, associate with mans (12, 13). In addition, some memory phenotype adaptor molecules or signaling partners important for signal trans- ␣␤TCRϩCD8ϩ T cells in humans have been shown to express duction (5). CD16 (14). We have previously described a population of One of the first activating receptors described on NK cells is ␣␤ ϩ ␣␤ϩ Fc␥RIII␣ or CD16. CD16 is a low affinity FcR that binds to IgG TCR CD8 T cells in normal B6 mice that exhibit a mem- and is involved in Ab-dependent cell-mediated cytotoxicity ory phenotype characterized by the expression of high levels of ␤ (ADCC),3 in which an Ab-coated target cell is destroyed by NK CD44, IL-2R , and Ly6C (15). These cells can be activated by cells (6). Stimulation of CD16 on NK cells also results in the cytokines such as IL-2 and IL-15, and upon activation they express production of cytokines, such as IFN-␥, TNF-␣, and GM-CSF (7). several functional NK receptors, including 2B4, CD94, and NKG2D as well as the NK adaptor protein DAP12. Using an H-Y TCR transgenic model, we have shown that the development of CD8ϩCD44high T cells is driven by the high affinity interaction of Department of Microbiology and Immunology, University of British Columbia, Van- couver, Canada the ␣␤TCR with cognate self-Ag (16). The H-Y TCR is specific b b Received for publication May 7, 2004. Accepted for publication November 9, 2004. for a male Ag (H-Y) presented by H-2D , and in H-2 H-Y female The costs of publication of this article were defrayed in part by the payment of page mice, the lack of male Ag results in the development of H-Y CD8 charges. This article must therefore be hereby marked advertisement in accordance T cells with a naive phenotype (CD44low). In H-2b H-Y male mice, with 18 U.S.C. Section 1734 solely to indicate this fact. in contrast, the presence of the cognate (H-Y) Ag results in the 1 This work was supported by grants from the Canadian Cancer Society and the development of a population of CD8ϩ T cells that is virtually Canadian Institutes of Health Research (to H.S.T.). S.D. is supported by the Natural Sciences and Engineering Research Council of Canada and the Michael Smith Foun- identical in cell surface and functional phenotypes with the mem- dation of Health Research. ory phenotype CD8ϩCD44high cells in normal B6 mice (16). Be- 2 Address correspondence and reprint requests to Dr. Hung-Sia Teh, Department of cause memory phenotype CD8ϩ T cells in normal and H-Y TCR Microbiology and Immunology, University of British Columbia, 6174 University Boulevard, Vancouver, British Columbia, Canada V6T 1Z3. E-mail address: transgenic mice are specific for self-Ags, we will refer to these ϩ [email protected] cells as self-specific CD8 T cells to distinguish them from con- ϩ ϩ 3 Abbreviations used in this paper: ADCC, Ab-dependent cell-mediated cytotoxicity. ventional memory CD8 T cells. Self-specific CD8 T cells from Copyright © 2005 by The American Association of Immunologists, Inc. 0022-1767/05/$02.00 1254 SELF-SPECIFIC CD8ϩ T CELLS EXPRESS AN ACTIVATING FcR both H-Y TCR transgenic (16) and nontransgenic (15) mice pref- sciences). CD3 immunoprecipitation was preformed by treating lysates erentially kill syngeneic tumor cells. This killing of syngenic tu- with preconjugated anti-CD3⑀/protein G-Sepharose beads for2hat4°C, mors involves the MHC-restricted ␣␤ TCR as well as the activat- followed by several washes. Complexes were then removed from the beads by resuspension in 2ϫ protein sample buffer, followed by boiling for 5 ing NK receptor, NKG2D, which results in non-MHC-restricted min. The samples were then run in a 4–15% Tris-HCl gel and immuno- lysis of target cells that express the NKG2D ligand, Rae-1 (16). blotted as described above. In this report we have described the expression and function of CD16 in self-specific CD8ϩ cells from B6 and male H-Y TCR Results transgenic mice. We showed that this FcR, comprising the Expression of Fc␥RIII␣/FcR␥ on activated self-specific Fc␥RIII␣/FcR␥ subunits, is similar in composition to the NK FcR. CD8ϩ cells Although this FcR is expressed at a low level in self-Ag-specific ϩ ϩ We have previously shown that self-specific CD8 T cells express CD8 T cells, it is particularly efficient at initiating the destruction an activated/memory phenotype (15, 16). Initially, ex vivo self- of Ab-coated target cells and can induce the production of two key specific CD8ϩ cells from B6 and male H-2b H-Y mice did not ␥ ␣ inflammatory cytokines, IFN- and TNF- .
Load more

Recommended publications
  • The Ligands for Human Igg and Their Effector Functions
    antibodies Review The Ligands for Human IgG and Their Effector Functions Steven W. de Taeye 1,2,*, Theo Rispens 1 and Gestur Vidarsson 2 1 Sanquin Research, Dept Immunopathology and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands; [email protected] 2 Sanquin Research, Dept Experimental Immunohematology and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands; [email protected] * Correspondence: [email protected] Received: 26 March 2019; Accepted: 18 April 2019; Published: 25 April 2019 Abstract: Activation of the humoral immune system is initiated when antibodies recognize an antigen and trigger effector functions through the interaction with Fc engaging molecules. The most abundant immunoglobulin isotype in serum is Immunoglobulin G (IgG), which is involved in many humoral immune responses, strongly interacting with effector molecules. The IgG subclass, allotype, and glycosylation pattern, among other factors, determine the interaction strength of the IgG-Fc domain with these Fc engaging molecules, and thereby the potential strength of their effector potential. The molecules responsible for the effector phase include the classical IgG-Fc receptors (FcγR), the neonatal Fc-receptor (FcRn), the Tripartite motif-containing protein 21 (TRIM21), the first component of the classical complement cascade (C1), and possibly, the Fc-receptor-like receptors (FcRL4/5). Here we provide an overview of the interactions of IgG with effector molecules and discuss how natural variation on the antibody and effector molecule side shapes the biological activities of antibodies. The increasing knowledge on the Fc-mediated effector functions of antibodies drives the development of better therapeutic antibodies for cancer immunotherapy or treatment of autoimmune diseases.
    [Show full text]
  • Antibody-Dependent Cellular Cytotoxicity Riiia and Mediate Γ
    Effector Memory αβ T Lymphocytes Can Express Fc γRIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity This information is current as Béatrice Clémenceau, Régine Vivien, Mathilde Berthomé, of September 27, 2021. Nelly Robillard, Richard Garand, Géraldine Gallot, Solène Vollant and Henri Vié J Immunol 2008; 180:5327-5334; ; doi: 10.4049/jimmunol.180.8.5327 http://www.jimmunol.org/content/180/8/5327 Downloaded from References This article cites 43 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/180/8/5327.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Effector Memory ␣␤ T Lymphocytes Can Express Fc␥RIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity1 Be´atrice Cle´menceau,*† Re´gine Vivien,*† Mathilde Berthome´,*† Nelly Robillard,‡ Richard Garand,‡ Ge´raldine Gallot,*† Sole`ne Vollant,*† and Henri Vie´2*† Human memory T cells are comprised of distinct populations with different homing potential and effector functions: central memory T cells that mount recall responses to Ags in secondary lymphoid organs, and effector memory T cells that confer immediate protection in peripheral tissues.
    [Show full text]
  • Epha Receptors and Ephrin-A Ligands Are Upregulated by Monocytic
    Mukai et al. BMC Cell Biology (2017) 18:28 DOI 10.1186/s12860-017-0144-x RESEARCHARTICLE Open Access EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/ maturation and promote cell adhesion and protrusion formation in HL60 monocytes Midori Mukai, Norihiko Suruga, Noritaka Saeki and Kazushige Ogawa* Abstract Background: Eph signaling is known to induce contrasting cell behaviors such as promoting and inhibiting cell adhesion/ spreading by altering F-actin organization and influencing integrin activities. We have previously demonstrated that EphA2 stimulation by ephrin-A1 promotes cell adhesion through interaction with integrins and integrin ligands in two monocyte/ macrophage cell lines. Although mature mononuclear leukocytes express several members of the EphA/ephrin-A subclass, their expression has not been examined in monocytes undergoing during differentiation and maturation. Results: Using RT-PCR, we have shown that EphA2, ephrin-A1, and ephrin-A2 expression was upregulated in murine bone marrow mononuclear cells during monocyte maturation. Moreover, EphA2 and EphA4 expression was induced, and ephrin-A4 expression was upregulated, in a human promyelocytic leukemia cell line, HL60, along with monocyte differentiation toward the classical CD14++CD16− monocyte subset. Using RT-PCR and flow cytometry, we have also shown that expression levels of αL, αM, αX, and β2 integrin subunits were upregulated in HL60 cells along with monocyte differentiation while those of α4, α5, α6, and β1 subunits were unchanged. Using a cell attachment stripe assay, we have shown that stimulation by EphA as well as ephrin-A, likely promoted adhesion to an integrin ligand- coated surface in HL60 monocytes. Moreover, EphA and ephrin-A stimulation likely promoted the formation of protrusions in HL60 monocytes.
    [Show full text]
  • T Cells the Usual Subsets
    T cells: the usual subsets Chen Dong and Gustavo J. Martinez T cells have important roles in immune responses and function by directly secreting soluble mediators or important for adaptation of immune responses in different microenvironments and might be particularly through cell contact-dependent mechanisms. Many T cell subsets have been characterized. Although relevant for host defence against pathogens that colonize different tissues. Distinct T cell subsets, or effector T cells were originally considered to be terminally differentiated, a growing body of evidence has differentiation states, can be identified based on the cell surface markers expressed and/or the effector challenged this view and suggested that the phenotype of effector T cells is not completely fixed but is molecules produced by a particular T cell population. This Poster summarizes our current understanding of more flexible or plastic. T cells can have ‘mixed’ phenotypes (that is, have characteristics usually the surface markers, transcriptional regulators, effector molecules and functions of the different T cell associated with more than one T cell subset) and can interconvert from one subset phenotype to another, subsets that participate in immune responses. Further knowledge of how these T cell subsets are regulated IMMUNOLOGY although instructive signalling can lead to long-term fixation of cytokine memory. T cell plasticity can be and cooperate with each other will provide us with better tools to treat immune-related diseases. Cytotoxic T cell Exhausted T cell
    [Show full text]
  • T Lymphocytes + and CD8 +CD4 TCR/CD3 Complex in Immortalized Mature -Deficient Γ Signaling Through A
    Signaling Through a CD3γ-Deficient TCR/CD3 Complex in Immortalized Mature CD4+ and CD8+ T Lymphocytes This information is current as Alberto Pacheco-Castro, David Alvarez-Zapata, Pilar of September 25, 2021. Serrano-Torres and José R. Regueiro J Immunol 1998; 161:3152-3160; ; http://www.jimmunol.org/content/161/6/3152 Downloaded from References This article cites 47 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/161/6/3152.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 25, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Signaling Through a CD3g-Deficient TCR/CD3 Complex in Immortalized Mature CD41 and CD81 T Lymphocytes1 Alberto Pacheco-Castro,2 David Alvarez-Zapata,2 Pilar Serrano-Torres, and Jose´R. Regueiro3 The biologic role of each CD3 chain and their relative contribution to the signals transduced through the TCR/CD3 complex and to downstream activation events are still controversial: they may be specialized or redundant.
    [Show full text]
  • 18F-Farag PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy
    Journal of Nuclear Medicine, published on November 6, 2020 as doi:10.2967/jnumed.120.249078 18F-FAraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy Jelena Levi1*, Samuel Goth1, Lyna Huynh1, Tina Lam1, Tony L Huynh2, Brailee Schulte2, Juliet A Packiasamy1 1CellSight Technologies Incorporated, San Francisco, California; 2Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California; *Corresponding Author Jelena Levi, PhD 185 Berry street, San Francisco, 94107, CA Email: [email protected] Running Title: [18F]F-AraG for CD8 profiling of tumors Financial statement: This work was supported by National Institutes of Health Grants NCI SBIR HHSN261201800024C (JL). Conflict of Interest Statement: JL, SG, LH, TL and JP are or were employed by CellSight Technologies. CellSight Technologies Incorporated is commercializing [18F]F-AraG as a PET tracer for evaluation of immune response in immunotherapy. No other potential conflicts of interest relevant to this article exist. ABSTRACT Majority of the clinical trials exploring various combinations of chemo- and immunotherapy rely on serial biopsy to provide information on immune response. The aim of this study was to assess the value of 18F-FAraG as a non-invasive tool that could profile tumors based on the key players in adaptive antitumor response, CD8+ cells, and evaluate immunomodulatory effects of chemotherapy. Methods. To evaluate the ability of 18F-FAraG to report on the presence of CD8+ cells within the TME, we imaged a panel of syngeneic tumor models (MC38, CT26, LLC, A9F1, 4T1 and B16F10), and correlated the signal intensity with the number of lymphocytes found in the tumors.
    [Show full text]
  • Slan Monocytes and Macrophages Mediate CD20-Dependent B-Cell
    Published OnlineFirst May 10, 2018; DOI: 10.1158/0008-5472.CAN-17-2344 Cancer Tumor Biology and Immunology Research slanþ Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCP William Vermi1,2, Alessandra Micheletti3, Giulia Finotti3, Cristina Tecchio4, Federica Calzetti3, Sara Costa3, Mattia Bugatti1, Stefano Calza5, Claudio Agostinelli6, Stefano Pileri7, Piera Balzarini1, Alessandra Tucci8, Giuseppe Rossi8, Lara Furlani4, Giuseppe Todeschini4, Alberto Zamo9, Fabio Facchetti1, Luisa Lorenzi1, Silvia Lonardi1, and Marco A. Cassatella3 Abstract þ Terminal tissue differentiation and function of slan monocytes in cancer þ + + is largely unexplored. Our recent studies demonstrated that slan mono- slan monocyte slan macrophage cytes differentiate into a distinct subset of dendritic cells (DC) in human CD16A þ tonsils and that slan cells colonize metastatic carcinoma-draining lymph CD32 nodes. Herein, we report by retrospective analysis of multi-institutional þ CD16A CD64 cohorts that slan cells infiltrate various types of non-Hodgkin lymphomas = RTX (NHL), particularly the diffuse large B-cell lymphoma (DLBCL) group, CD20 þ CD20 including the most aggressive, nodal and extranodal, forms. Nodal slan cells displayed features of either immature DC or macrophages, in the latter case ingesting tumor cells and apoptotic bodies. We also found in patients þ þ with DLBCL that peripheral blood slan monocytes, but not CD14 monocytes, increased in number and displayed highly efficient rituxi- Lymphoma cell Lymphoma cell mab-mediated antibody-dependent cellular cytotoxicity, almost equivalent + RTX þ to that exerted by NK cells. Notably, slan monocytes cultured in condi- tioned medium from nodal DLBCL (DCM) acquired a macrophage-like + RTX phenotype, retained CD16 expression, and became very efficient in ritux- imab-mediated antibody-dependent cellular phagocytosis (ADCP).
    [Show full text]
  • CD29 Identifies IFN-Γ–Producing Human CD8+ T Cells With
    + CD29 identifies IFN-γ–producing human CD8 T cells with an increased cytotoxic potential Benoît P. Nicoleta,b, Aurélie Guislaina,b, Floris P. J. van Alphenc, Raquel Gomez-Eerlandd, Ton N. M. Schumacherd, Maartje van den Biggelaarc,e, and Monika C. Wolkersa,b,1 aDepartment of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; bLandsteiner Laboratory, Oncode Institute, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; cDepartment of Research Facilities, Sanquin Research, 1066 CX Amsterdam, The Netherlands; dDivision of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; and eDepartment of Molecular and Cellular Haemostasis, Sanquin Research, 1066 CX Amsterdam, The Netherlands Edited by Anjana Rao, La Jolla Institute for Allergy and Immunology, La Jolla, CA, and approved February 12, 2020 (received for review August 12, 2019) Cytotoxic CD8+ T cells can effectively kill target cells by producing therefore developed a protocol that allowed for efficient iso- cytokines, chemokines, and granzymes. Expression of these effector lation of RNA and protein from fluorescence-activated cell molecules is however highly divergent, and tools that identify and sorting (FACS)-sorted fixed T cells after intracellular cytokine + preselect CD8 T cells with a cytotoxic expression profile are lacking. staining. With this top-down approach, we performed an un- + Human CD8 T cells can be divided into IFN-γ– and IL-2–producing biased RNA-sequencing (RNA-seq) and mass spectrometry cells. Unbiased transcriptomics and proteomics analysis on cytokine- γ– – + + (MS) analyses on IFN- and IL-2 producing primary human producing fixed CD8 T cells revealed that IL-2 cells produce helper + + + CD8 Tcells.
    [Show full text]
  • Identification of 18 Immune Cell Subsets Using 13-Color Panel
    Immunophenotyping Identification of 18 immune cell subsets in human blood using a 13-color panel Background Cell type Function Phenotype Flow cytometry has become the method of choice for Eosinophils Parasitic immunity CD45+, SSCmid/hi, CD14 –, CD16 –, CD19– immunophenotyping and identifying specific cellular + mid/hi subsets. Within seconds, it provides a thorough overview of Neutrophils Innate Immunity CD45 , SSC , CD14 –, CD16+, CD19– the major cell types that constitute a sample. Using multiple + mid markers simultaneously increases the number of parameters Classical Phagocytosis of CD45 , SSC , monocytes pathogens and CD14+, CD16– that can be analyzed per run and decreases the amount of antigen presentation starting material required to perform an assay. This can be Intermediate Phagocytosis of CD45+, SSCmid, critical for precious sample material and long-term immune- monocytes pathogens and CD14+, CD16mid monitoring studies. In this application note, we demonstrate antigen presentation 13-color immunophenotyping of human peripheral blood Non-classical Phagocytosis of CD45+, SSCmid, + + mononuclear cells (PBMCs) using the MACSQuant® Analyzer 16, monocytes pathogens and CD14 , CD16 antigen presentation a compact and reliable benchtop flow cytometer equipped + low + with three lasers. The markers selected allow for the Class-switched Adaptive immunity CD45 , SSC , CD19 , memory B cells CD27+, IgD–, CD14– simultaneous identification and analysis of 18 different cell Non-switched Adaptive immunity CD45+, SSClow, CD19+, populations, thus maximizing the amount of information that memory B cells CD27+, IgD+, CD14– can be retrieved from the sample material analyzed. This is Naive B cells Adaptive immunity – CD45+, SSClow, CD19+, critical when input material is limited, as is often the case for non-antigen CD27–, IgD+, CD14– pediatric or disease studies.
    [Show full text]
  • CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1
    bioRxiv preprint doi: https://doi.org/10.1101/329938; this version posted May 24, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 2 Transcription in Treated Aviremic Individuals 3 Alessandra Notoa, Francesco A. Procopioa, Riddhima Bangaa, Madeleine Suffiottia, Jean-Marc 4 Corpatauxb, Matthias Cavassinic, Craig Fenwicka, Raphael Gottardod, Matthieu Perreaua, 5 Giuseppe Pantaleoa,e# 6 7 aService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 8 Lausanne, Switzerland 9 bService of Vascular Surgery, Lausanne University Hospital, University of Lausanne, Lausanne, 10 Switzerland 11 cService of Infectious Diseases, Lausanne University Hospital, University of Lausanne, 12 Lausanne, Switzerland 13 dVaccine and Infectious Disease Divisions, Fred Hutchinson Cancer Research Center, Seattle, 14 Washington, USA 15 eSwiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, 16 Lausanne, Switzerland 17 Running Head: Role of CD32 and PD-1 in Defining the HIV Reservoir 18 #Address correspondence to Giuseppe Pantaleo, [email protected] 19 Word count for the abstract: 318 Word count for the text: 4130 20 1 bioRxiv preprint doi: https://doi.org/10.1101/329938; this version posted May 24, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 21 ABSTRACT 22 A recent study conducted in blood has proposed CD32 as the marker identifying the ‘elusive’ HIV 23 reservoir. We have investigated the distribution of CD32+ CD4 T cells in blood and lymph nodes 24 (LNs) of healthy HIV-1 uninfected, viremic untreated and long-term treated HIV-1 infected 25 individuals and their relationship with PD-1+ CD4 T cells.
    [Show full text]
  • Cd4/Cd8 Panel, Blood
    Lab Dept: Flow and Immunology Test Name: CD4/CD8 PANEL, BLOOD General Information Lab Order Codes: C48P Synonyms: Helper/Suppressor Ratio; T- cells; T-cell subsets; T-cell phenotyping See also: Immune Status Panel and Comprehensive Immune Status Panel CPT Codes: 86359 – T cells, total count 86360 – T cells; absolute CD4 and CD8 count, including ratio Test Includes: CD4(CD3+) and CD8(CD3+) relative percentages, absolute values and a calculated Helper/Suppressor ratio. Logistics Test Indications: This is a minimal antibody panel to monitor immune status. Lab Testing Sections: Flow Cytometry Phone Numbers: MIN Lab: 612-813-6280 STP Lab: 651-220-6550 Test Availability: 3 times weekly determined by volume. Transport collected specimen immediately to Flow Cytometry. Routine testing is not available on weekends or holidays. Therefore, specimens cannot be used if drawn the day before a 3 day weekend such as Memorial Day, Labor Day or major holiday that falls on a Monday or Friday. Turnaround Time: 1 – 3 days Special Instructions: See Test Availability Specimen Specimen Type: Whole blood Container: Lavender top (EDTA) tube Draw Volume: 2 mL blood in a 2 mL Lavender (EDTA) tube Minimum volume: 0.5 mL in an EDTA microtainer Collection: Routine venipuncture Special Processing: Keep sample at room temperature and forward promptly to the laboratory. Do not centrifuge, refrigerate, or freeze sample. Patient Preparation: None Sample Rejection: Specimens will not be processed that are clotted; hemolyzed; greater than 72 hours old; collected in the wrong tube type (0.5 mL in a 2 mL tube), or that have been held or handled at a temperature other than room temperature Interpretive Reference Range: Age-dependant reference ranges provided with results.
    [Show full text]
  • Delayed Onset of Autoreactive Antibody Production and M2
    www.nature.com/scientificreports OPEN Delayed onset of autoreactive antibody production and M2- skewed macrophages contribute to Received: 6 October 2017 Accepted: 9 January 2018 improved survival of TACI defcient Published: xx xx xxxx MRL-Fas/Lpr mouse Lunhua Liu1, Windy Rose Allman1, Adam Steven Coleman1, Kazuyo Takeda2, Tsai-Lien Lin3 & Mustafa Akkoyunlu1 Anti-B cell activating factor belonging to TNF-family (BAFF) antibody therapy is indicated for the treatment of patients with active systemic lupus erythematosus (SLE). We hypothesized that the BAFF receptor, transmembrane activator and calcium-modulator and cyclophilin interactor (TACI) may be responsible for the generation of antibody secreting plasma cells in SLE. To test this hypothesis, we generated TACI defcient MRL-Fas/Lpr (LPR-TACI−/−) mouse. TACI defciency resulted in improved survival of MRL-Fas/Lpr mice and delayed production of anti-dsDNA and anti-SAM/RNP antibodies. There was also a delay in the onset of proteinuria and the accumulation of IgG and infammatory macrophages (Mφs) in the glomeruli of young LPR-TACI−/− mice compared to wild-type mice. Underscoring the role of TACI in infuencing Mφ phenotype, the transfer of Mφs from 12-week-old LPR- TACI−/− mice to age-matched sick wild-type animals led to a decrease in proteinuria and improvement in kidney pathology. The fact that, in LPR-TACI−/− mouse a more pronounced delay was in IgM and IgG3 autoreactive antibody isotypes and the kinetics of follicular helper T (Tf) cell-development was comparable between the littermates suggest a role for TACI in T cell-independent autoantibody production in MRL-Fas/Lpr mouse prior to the onset of T cell-dependent antibody production.
    [Show full text]